Elevated B-Type Natriuretic Peptide Is Associated With Increased In-Hospital Mortality or Cardiac Arrest in Patients Undergoing Implantable Cardioverter-Defibrillator Implantation
Wei S, Loyo-Berríos NI, Haigney MC, Cheng H, Pinnow EE, Mitchell KR, Beachy JH, Woodward AM, Wang Y, Curtis JP, Marinac-Dabic D. Elevated B-Type Natriuretic Peptide Is Associated With Increased In-Hospital Mortality or Cardiac Arrest in Patients Undergoing Implantable Cardioverter-Defibrillator Implantation. Circulation Cardiovascular Quality And Outcomes 2011, 4: 346-354. PMID: 21487093, DOI: 10.1161/circoutcomes.110.943621.Peer-Reviewed Original ResearchConceptsElevated BNP levelsHospital mortalityCardiac arrestBNP levelsICD implantationElevated B-type natriuretic peptide (BNP) levelsNational Cardiovascular Data Registry ICD RegistryB-type natriuretic peptide levelsElevated B-type natriuretic peptideIncreased In-Hospital MortalityB-type natriuretic peptideImplantable cardioverter defibrillator implantationBiventricular ICD implantationHigh BNP groupNatriuretic peptide levelsIn-Hospital MortalityCardioverter-defibrillator implantationHierarchical logistic regressionBNP measurementHospital deathPeriprocedural complicationsRenal dysfunctionComplication rateBNP groupHeart failure